Displaying drugs 426 - 450 of 652 in total
G207
G207 is cancer-killing viruses, so-called oncolytic viruses, for the treatment of various forms of cancer developed by MediGene AG. These viruses are specific herpes simplex viruses, or HSVs, generally known as the cause of cold sores. MediGene uses these viruses, however, in a modified and "disarmed" form in order to...
Investigational
Vasomera
Investigational
Thallous cation Tl-201
Experimental
Nangibotide
Nangibotide is under investigation in clinical trial NCT04055909 (Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock).
Investigational
PMX-205
Investigational
ABO-201
Investigational
Terevalefim
Terevalefim is under investigation in clinical trial NCT02474667 (Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney).
Investigational
EGT-201
EGT-201 is an adeno-associated viral vector serotype 9 (AAV9) vector-based gene therapy consisting of the alpha-N-acetyglucosaminidase (NAGLU) transgene. Developed by Esteve Pharmaceuticals, it is being investigated for Sanfilippo syndrome type B.
Investigational
Gildeuretinol
Investigational
Chitosan low molecular weight (20-200 mpa.s)
Experimental
Matched Synonyms: … Poliglusam low molecular weight (20-200 mpa.s) …
Matched Name: … Chitosan low molecular weight (20-200 mpa.s) …
Matched Name: … Chitosan low molecular weight (20-200 mpa.s) …
Ezeprogind
Investigational
Namilumab
Namilumab has been used in trials studying the treatment of Plaque Psoriasis and Rheumatoid Arthritis.
Investigational
P-2045 Re-188
Investigational
Fletikumab
Fletikumab is under investigation in clinical trial NCT01038674 (Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis).
Investigational
Matched Synonyms: … Anti-IL-20 …
Matched Description: … Fletikumab is under investigation in clinical trial NCT01038674 (Safety and Tolerability of Anti-IL-20 …
Matched Description: … Fletikumab is under investigation in clinical trial NCT01038674 (Safety and Tolerability of Anti-IL-20 …
Acetylcysteine zidrimer
Investigational
Zamtocabtagene autoleucel
Investigational
Zeluvalimab
Zeluvalimab is under investigation in clinical trial NCT04631601 (Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (Mcrpc)).
Investigational
3,20-Pregnanedione
Experimental
Icotinib
Icotinib is a potent and specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)
Icotinib was approved in China by the SFDA in June, 2011 and in January 2014, Beta Pharma, Inc. was given a “May Proceed” from the US FDA to conduct a Phase I study for the...
Experimental
Investigational
PBCAR20A
Investigational
Thallium Tl-201
Thallium Tl-201 is under investigation in clinical trial NCT02697760 (The CZT Dynamic Myocardial Perfusion Imaging).
Investigational
T-2000
T2000 has been used in trials studying the treatment of Myoclonus and Essential Tremor.
Investigational
IO-202
IO-202 is a first-in-class antibody targeting the Leukocyte Immunoglobulin-Like Receptor subfamily B (LILRB) member 4 (LILRB4). It is being investigated in cancers.
Investigational
BN-201
Investigational
TN-201
TN-201 is a gene therapy comprising a native AAV9 capsid with a genomic cassette containing a cardiomyocyte-specific promoter and the wild-type human MYBPC3 gene.
Investigational
Displaying drugs 426 - 450 of 652 in total